Medicinal Plants for Major Depressive Disorder.

Area of Science:

• Integrative Psychiatry
• Pharmacognosy
• Neuroscience

Background:

• Major Depressive Disorder (MDD) presents significant challenges with conventional treatments, leading to interest in alternative therapies.
• Medicinal plants offer multi-targeted mechanisms for MDD, including neurotransmitter modulation, anti-inflammation, and HPA axis regulation.

Purpose of the Study:

• To review the therapeutic potential of key medicinal plants for Major Depressive Disorder (MDD).
• To examine the mechanisms of action, pharmacokinetics, and risks associated with these plant-based therapies.

Main Methods:

• Literature review of established and emerging medicinal plants for MDD.
• Analysis of scientific data on plant compounds, their biological effects, and clinical evidence.

Main Results:

• Key plants like St. John's Wort and Rhodiola show therapeutic promise for MDD.
• Emerging candidates include Turmeric, Ashwagandha, Ginseng, and Gotu Kola.
• Challenges include complex pharmacokinetics, adverse effects, and quality control issues.

Conclusions:

• Medicinal plants offer a promising avenue for MDD management, complementing conventional treatments.
• Further research is needed to optimize their use, standardize preparations, and ensure safety.